Digirad Corporation (DRAD) 5.22 $DRAD 7 Medical Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Digirad Corporation (DRAD) 5.22 $DRAD

7 Medical Stocks to Buy with Market-Beating Yields
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:50AM CDT
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market.
KND: 11.59 (+0.24), ABT: 39.63 (+0.89), JNJ: 117.38 (+0.92), PFE: 34.59 (+0.12), BMY: 72.64 (+0.33), HLS: 40.82 (+0.69), DRAD: 5.22 (+0.05)

Digirad Corporation to Present at the East Coast IDEAS Investor Conference on June 29, 2016
GlobeNewswire - Wed Jun 08, 5:00AM CDT
Digirad Corporation (NASDAQRAD), the leader in providing healthcare solutions on an as needed, when needed, and where needed basis, today announced that it will present at the East Coast IDEAS Investor Conference on Wednesday, June 29, 2016, at the Boston Park Plaza in Boston, MA.
DRAD: 5.22 (+0.05)

Omnicell Grows amid Weak Margins, Hospital Spending Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:57AM CDT
On Jun 1, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
MDSO: 46.51 (+1.39), DRAD: 5.22 (+0.05), OMCL: 33.51 (+0.75), ATHN: 132.82 (+3.94)

DMS Health Showcases State-Of-The-Art Mobile Healthcare Clinic at Annual Rolling Thunder Rally in Washington, D.C., Memorial Day Weekend
GlobeNewswire - Wed May 18, 3:00PM CDT
DMS Health Technologies, a Digirad Company (NASDAQRAD) and a leader in mobile healthcare, and TrillaMed, a Service-Disabled Veteran-Owned Small Business that is operated, managed and owned by three combat veterans who served as U.S. Army Airborne Rangers, today announced their participation in the Rolling Thunder Memorial Day weekend gathering at the Vietnam and Lincoln Memorials in Washington. This event is the world's largest single-day motorcycle rally, drawing over one million veterans, spectators and patriots to the nation's capital annually.
DRAD: 5.22 (+0.05)

Digirad (DRAD) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:20AM CDT
Digirad Corporation (DRAD) has been struggling lately, but the selling pressure may be coming to an end soon
DRAD: 5.22 (+0.05)

Digirad posts 1Q profit
Automated Insights - Fri Apr 29, 9:24AM CDT
SUWANEE, Ga. (AP) _ Digirad Corp. (DRAD) on Friday reported first-quarter net income of $11.6 million.
DRAD: 5.22 (+0.05)

Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2016
GlobeNewswire - Fri Apr 29, 4:00AM CDT
-- Announces year over year Q1 revenue and adjusted EBITDA growth of 125% and 345%, respectively
DRAD: 5.22 (+0.05)

Digirad Corporation Announces Quarterly Dividend of $0.05 Per Share
GlobeNewswire - Mon Feb 01, 3:30PM CST
Digirad Corporation (NASDAQRAD) today announced a quarterly cash dividend of $0.05 per share. The dividend is payable on February 29, 2016 to shareholders of record as of February 16, 2016.
DRAD: 5.22 (+0.05)

Digirad Corporation Announces Closing of DMS Health Technologies Acquisition and Associated Financing From Wells Fargo
GlobeNewswire - Tue Jan 05, 8:00AM CST
Digirad Corporation (NASDAQRAD) ("Digirad" or the "Company", the leader in providing healthcare solutions on an as needed, when needed, and where needed basis, announced today that it has closed the acquisition of DMS Health Technologies, Inc. ("DMS Health" as of January 1, 2016.
WFC: 47.91 (+0.94), DRAD: 5.22 (+0.05)

How it All Plays Out - Analyst Notes on VimpelCom, Digirad, Compania de Minas Buenaventura and Companhia de Saneamento Basico do Estado de Sao Paulo
ACCESSWIRE - Wed Dec 23, 7:00AM CST
NEW YORK, NY ACCESSWIRE / December 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: VimpelCom Ltd. (NASDAQ: VIP), Digirad Corp. (NASDAQ: DRAD), Compania de Minas Buenaventura SAA (NYSE: BVN) and Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (NYSE: SBS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
VIP: 3.84 (+0.03), SBS: 8.55 (+0.17), BVN: 10.74 (-0.04), DRAD: 5.22 (+0.05)

New Strong Buy Stocks for December 11th
Zacks Equity Research - Zacks Investment Research - Fri Dec 11, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
DSCI: 4.01 (+0.02), CTG: 5.01 (+0.01), EARS: 4.00 (-0.05), DRAD: 5.22 (+0.05)

Digirad Corporation to Present at the LD Micro Main Event on December 2, 2015
GlobeNewswire - Wed Nov 18, 3:00PM CST
Digirad Corporation (NASDAQRAD), the leader in providing healthcare solutions on an as needed, when needed and where needed basis, today announced that it will present at the eighth annual LD Micro Conference. The three-day conference will host more than 200 companies in the micro-cap space and will take place December 1-3 at the Luxe Sunset Boulevard Hotel in Los Angeles.
DRAD: 5.22 (+0.05)

Allscripts Q3 Earnings Beat, Revenues Miss by a Whisker
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 8:54AM CST
Allscripts Healthcare Solutions, Inc. (MDRX) reported adjusted earnings of 10 cents (including stock-based compensation) per share in the third quarter of 2015.
BABY: 36.55 (+0.89), STRM: 1.18 (-0.06), MDRX: 12.63 (+0.15), DRAD: 5.22 (+0.05)

Omnicell Misses Q3 Earnings, Revenues; Lowers Top-Line View
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 11:00AM CST
Omnicell, Inc. (OMCL) reported third-quarter 2015 adjusted earnings per share of 25 cents, up 13.6% from the year-ago number.
STRM: 1.18 (-0.06), QSII: 12.08 (+0.34), DRAD: 5.22 (+0.05), OMCL: 33.51 (+0.75)

Digirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2015
GlobeNewswire - Fri Oct 30, 5:07AM CDT
-- Announces year over year quarterly revenue and adjusted EBITDA growth of 14% and 30% respectively
DRAD: 5.22 (+0.05)

Digirad Corporation to Release 2015 Third Quarter and Nine Month Financial Results on October 30, 2015
GlobeNewswire - Wed Oct 28, 3:00PM CDT
Digirad Corporation (NASDAQRAD) will release financial results for its third quarter and nine months ended September 30, 2015, before the market opens on Friday, October 30, 2015.
DRAD: 5.22 (+0.05)

Will Digirad (DRAD) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 9:38AM CDT
As of late, it has definitely been a great time to be an investor in Digirad Corporation (DRAD)
DRAD: 5.22 (+0.05)

Platinum Equity announces divestiture of DMS Health Technologies to Digirad for undisclosed value
M2 - Thu Oct 15, 5:04AM CDT
Platinum Equity reported on Wednesday the launch of a definitive agreement to divest its DMS Health Technologies to Digirad (NASDAQRAD) by the end of 2015.
DRAD: 5.22 (+0.05)

Platinum Equity to Sell DMS Health Technologies to Digirad Corporation
Marketwired - Wed Oct 14, 5:11AM CDT
Platinum Equity today announced it has signed a definitive agreement to sell DMS Health Technologies ("DMS Health" to Digirad Corporation (NASDAQ: DRAD). The transaction is expected to close by the end of 2015.
DRAD: 5.22 (+0.05), OTTR: 32.52 (-0.32)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Economic Impact of Trump's Trade Deal: What Comes Next?

Updated Category News Views 270

Trade Deal Analysis and Its Implications President Donald Trump’s recent trade agreement with the European Union has sparked a wave of criticism from economists across the board. The general consensus among experts is that the deal could have adverse effects on American consumers and businesses alike. Insights from Notable Economists Economist Peter Schiff shared his...

Continue Reading
Innovative Navigation Solutions from NAL Research and Partners

Updated Category News Views 369

Strategic Collaboration Enhances Maritime Navigation In an exciting partnership, NAL Research, a leader in Assured Positioning, Navigation, and Timing (APNT) solutions, has joined forces with SGM Technology AS and Tschudi Shipping Company to create innovative navigation and tracking solutions tailored for the commercial maritime sector. This collaboration aims to tackle...

Continue Reading
Global Ready-Mix Concrete Market Set for Remarkable Growth

Updated Category News Views 187

Ready-mix Concrete Market Overview Ready-mix concrete (RMC) is reshaping global construction with a projected size of USD 1824.29 billion by 2033, according to recent insights. In 2025, it's estimated at USD 989.25 billion, reflecting a robust compound annual growth rate (CAGR) of 8.06% from 2026 to 2033. This growth can be credited to rampant urbanization, robust...

Continue Reading
NevGold Reports Strong Antimony Recovery at Limo Butte Project

Updated Category News Views 105

Positive Metallurgical Test Results from NevGold Vancouver, British Columbia – NevGold Corp. (“NevGold” or the “Company”) (TSXV: NAU) (OTCQX: NAUFF) (Frankfurt: 5E50) is excited to share impressive results from its recent metallurgical testwork at the Limousine Butte Project. This site has gained recognition as a promising area for mining, particularly for its...

Continue Reading
Exploring Arbutus Biopharma's Financial Success and Future Ahead

Updated Category News Views 192

Arbutus Biopharma Posts Strong Financial Results Arbutus Biopharma Corporation (NASDAQ: ABUS) reported a notable total revenue of $10.7 million for the second quarter of 2025, representing a significant increase compared to previous earnings. This financial growth encompasses deferred revenue linked to the reacquisition of rights to imdusiran, an innovative treatment the...

Continue Reading